Table 1.
Patient characteristics, histology, and follow-up.
| Pat. | Gender | Age at Dx (years) |
Tumor size (cm) | Preoperative serum CT level (Ref.) | TNM/ tumor cells positive for CT |
Postoperative serum CT level (Ref.) |
Follow-up (mo.)/ Status |
|---|---|---|---|---|---|---|---|
| 1(471) | F | 68 | 4 | 103 pg/mL (<5) | pT2 pN0 (0/12), pM1 (Hepar), G2, L1 V1 R2 Hepar); 5% |
86.9 pg/mL (<5) | 36 DOD |
| 2(649) | M | 54 | 13 | 1,586 pg/mL (<11.6) | pT3, pN1 (7/22), M0, G2, L0, V1, Pn0, R0; 20% |
2.3 pg/mL (<5) | 80 NED |
| 3(728) | M | 69 | 7.5 | 139 pg/mL (<8.4) | pT2, pN0 (0/16), M0, G2, R0, L0, V0, Pn0, R0; 10% |
<2 pg/mL (<8.4) | 63 NED |
| 4(882) | F | 62 | 11.3 | 149.5 pg/mL (<9.8) | pT3 pN1 (1/12) pM1 (Hepar), G1, L1 V1 Pn0 R0; 5% |
<0.5 pg/mL (<9.8) | 23 NED |
| 5(879) | F | 67 | 3.5 | 88 pg/mL (<9.8) | pT2 pN0(0/16), M0, G2, L0, V0 Pn0 R0; 5% |
<0.5 pg/mL (<9.8) | 20 NED |
Dx, diagnosis; CT, calcitonin; Ref., reference value; mo., months; NED, no evidence of disease; DOD, dead of disease.